Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 29.35
-0.10 (-0.34%)
At close: Oct 16, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 2.21 billion as of October 16, 2026. It is the 27,998th most valuable company in the world and the 1,596th biggest in Taiwan.
Market Cap
2.21B
Enterprise Value
1.57B
Revenue
n/a
Global Rank
Country Rank
#1,596 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 2.21B, a decrease of -37.75%. That is a compound annual growth rate of -44.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 2.21B | -40.35% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taho Pharmaceuticals | 11.48B |
| Pharmasaga | 8.43B |
| Protect Animal Health | 2.71B |
| TEH SENG Pharmaceutical Mfg. | 2.45B |
| Anbogen Therapeutics | 1.93B |
| Gin Hwa Biotech Incorporation | 1.78B |
| Timing Pharmaceutial | 1.73B |
| Anya Biopharm | 1.60B |